T1	Intervention 556 695	Brachial artery flow-mediated dilation (FMD) and digital vascular function were measured at baseline and after each 6-week treatment period
T2	Intervention 452 554	sulfasalazine, an inhibitor of NFÎºB, and placebo in a randomized, double-blind, crossover study design
